Philadelphia Pharmaceuticals Company's latest marketcap:
As of 04/30/2026, Philadelphia Pharmaceuticals Company's market capitalization has reached $16.42 M. According to our data, Philadelphia Pharmaceuticals Company is the 39426th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 16.42 M |
| Revenue (ttm) | 12.95 M |
| Net Income (ttm) | 1.42 M |
| Shares Out | 7.5 M |
| EPS (ttm) | 0.19 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 03/30/2026 |
| Earnings Date | 04/23/2026 |
Philadelphia Pharmaceuticals Company's yearly market capitalization.
| Date | Market Cap(د.أ) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 05/21/2026 | د.أ12.9 M | $18.22 M | 7.5% | n/a |
| 12/31/2025 | د.أ12 M | $16.95 M | 6.67% | n/a |
| 12/17/2024 | د.أ11.25 M | $15.85 M | 4.9% | n/a |
| 12/19/2023 | د.أ10.72 M | $15.11 M | 2.88% | n/a |
| 12/15/2022 | د.أ10.42 M | $14.67 M | 1.46% | n/a |
| 12/23/2021 | د.أ10.28 M | $14.49 M | -4.2% | n/a |
| 12/31/2020 | د.أ10.72 M | $0 | n/a |
Company Profile
Philadelphia Pharmaceuticals Company develops, manufactures, and markets human pharmaceutical products, cosmetics, and medical devices of various therapeutic categories in Jordan.
The company provides products for skin related disorders, including anti-lice and scabicides preparations, antiseptics and disinfectants, bleaching and hyperpigmentation disorders preparations, emollients and protectives, keratolytics/topical psoriasis treatment preparations, and skin healing agents, as well as agents for dermatitis; and topical acne preparation, anti-pruritic, anti-viral, plain antifungal and anti-infective, plain steroid, steroids with antifungal/anti-infective combination, and skin recoloring products.
It also offers products for women health, such as vaginal antifungals, alkalinizing and cleansing agents, antimicrobials, germicidal fungicidal, antiseptics and hemostatic, and vaginal progesterone; and products in the areas of alimentary, gastrointestinal system, anti-inflammatory, analgesic, antipyretic, dental-oropharyngeal, hair care, local anesthetics, and respiratory system, as well as supplements and health care-OTC products.
The company also exports its products in the Middle East and North Africa region. Philadelphia Pharmaceuticals Company was founded in 1993 and is headquartered in Amman, Jordan.
Frequently Asked Questions
-
What is Philadelphia Pharmaceuticals Company's (ASE-PHIL) current market cap?As of 04/30/2026, Philadelphia Pharmaceuticals Company (including the parent company, if applicable) has an estimated market capitalization of $16.42 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Philadelphia Pharmaceuticals Company (ASE-PHIL) rank globally by market cap?Philadelphia Pharmaceuticals Company global market capitalization ranking is approximately 39426 as of 04/30/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.